ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

IRTC iRhythm Technologies Inc

88.13
1.38 (1.59%)
31 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
iRhythm Technologies Inc NASDAQ:IRTC NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.38 1.59% 88.13 80.07 88.88 88.48 86.09 87.13 498,879 01:00:00

iRhythm Technologies to Host Analyst & Investor Day on September 21, 2022

31/08/2022 1:30pm

GlobeNewswire Inc.


iRhythm Technologies (NASDAQ:IRTC)
Historical Stock Chart


From May 2022 to May 2024

Click Here for more iRhythm Technologies Charts.

iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the Company will host an Analyst & Investor Day on Wednesday, September 21, 2022, in New York City.

A live webcast of the event will begin at 9:00 a.m. ET and will be accessible at that time on the investors section of the Company’s website at investors.irhythmtech.com. A replay of the webcast and related presentation materials will be made available on the Company’s website following the conclusion of the event.

About iRhythm Technologies, Inc.iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients.

Investor Relations ContactStephanie Zhadkevich(919) 452-5430stephanie.zhadkevich@irhythmtech.com

iRhythm Media ContactMorgan Mathis(310) 528-6306irhythm@highwirepr.com

1 Year iRhythm Technologies Chart

1 Year iRhythm Technologies Chart

1 Month iRhythm Technologies Chart

1 Month iRhythm Technologies Chart